Jane Street’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $96.1M | Sell |
1,338,700
-916,600
| -41% | -$70.6M | 0.01% | 661 |
|
|
2025
Q4 | $179M | Sell |
2,255,300
-207,000
| -8% | -$16.3M | 0.03% | 388 |
|
|
2025
Q3 | $186M | Sell |
2,462,300
-55,000
| -2% | -$3.77M | 0.03% | 372 |
|
|
2025
Q2 | $174M | Sell |
2,517,300
-429,900
| -15% | -$28.2M | 0.03% | 320 |
|
|
2025
Q1 | $200M | Sell |
2,947,200
-1,388,700
| -32% | -$83.1M | 0.05% | 228 |
|
|
2024
Q4 | $195M | Buy |
4,335,900
+2,235,300
| +106% | +$125M | 0.04% | 254 |
|
|
2024
Q3 | $132M | Buy |
2,100,600
+34,100
| +2% | +$1.99M | 0.03% | 307 |
|
|
2024
Q2 | $122M | Buy |
2,066,500
+1,631,400
| +375% | +$102M | 0.03% | 335 |
|
|
2024
Q1 | $34.7M | Sell |
435,100
-47,400
| -10% | -$3.62M | 0.01% | 828 |
|
|
2023
Q4 | $38.1M | Sell |
482,500
-91,500
| -16% | -$6.51M | 0.01% | 823 |
|
|
2023
Q3 | $40.1M | Sell |
574,000
-25,600
| -4% | -$1.81M | 0.01% | 661 |
|
|
2023
Q2 | $41.5M | Buy |
599,600
+51,600
| +9% | +$3.67M | 0.01% | 699 |
|
|
2023
Q1 | $40.7M | Sell |
548,000
-35,100
| -6% | -$2.94M | 0.02% | 605 |
|
|
2022
Q4 | $54.3M | Buy |
583,100
+390,700
| +203% | +$37.7M | 0.03% | 490 |
|
|
2022
Q3 | $18.3M | Sell |
192,400
-411,400
| -68% | -$40.7M | 0.01% | 1143 |
|
|
2022
Q2 | $55.9M | Buy |
603,800
+120,400
| +25% | +$11.8M | 0.02% | 511 |
|
|
2022
Q1 | $48.9M | Buy |
483,400
+81,300
| +20% | +$8.54M | 0.02% | 689 |
|
|
2021
Q4 | $41.5M | Sell |
402,100
-18,000
| -4% | -$1.66M | 0.01% | 740 |
|
|
2021
Q3 | $35.6M | Buy |
420,100
+138,100
| +49% | +$11.6M | 0.01% | 756 |
|
|
2021
Q2 | $23.5M | Buy |
282,000
+17,500
| +7% | +$1.43M | 0.01% | 966 |
|
|
2021
Q1 | $19.9M | Sell |
264,500
-220,100
| -45% | -$16M | 0.01% | 977 |
|
|
2020
Q4 | $33.1M | Sell |
484,600
-76,500
| -14% | -$4.98M | 0.02% | 605 |
|
|
2020
Q3 | $32.8M | Buy |
561,100
+272,000
| +94% | +$16.9M | 0.02% | 542 |
|
|
2020
Q2 | $18.8M | Sell |
289,100
-65,700
| -19% | -$4.14M | 0.01% | 792 |
|
|
2020
Q1 | $21.1M | Buy |
354,800
+283,000
| +394% | +$18.9M | 0.02% | 437 |
|
|
2019
Q4 | $5.33M | Sell |
71,800
-8,900
| -11% | -$625K | 0.01% | 1030 |
|
|
2019
Q3 | $5.09M | Sell |
80,700
-50,500
| -38% | -$2.99M | 0.01% | 977 |
|
|
2019
Q2 | $7.15M | Sell |
131,200
-341,100
| -72% | -$18.4M | 0.01% | 826 |
|
|
2019
Q1 | $25.5M | Buy |
472,300
+374,200
| +381% | +$23.1M | 0.04% | 338 |
|
|
2018
Q4 | $6.43M | Buy |
98,100
+62,800
| +178% | +$4.69M | 0.01% | 784 |
|
|
2018
Q3 | $2.78M | Sell |
35,300
-68,700
| -66% | -$4.91M | 0.01% | 1566 |
|
|
2018
Q2 | $6.69M | Buy |
104,000
+38,200
| +58% | +$2.52M | 0.02% | 835 |
|
|
2018
Q1 | $4.09M | Sell |
65,800
-4,600
| -7% | -$330K | 0.01% | 1130 |
|
|
2017
Q4 | $5.1M | Buy |
70,400
+14,400
| +26% | +$1.05M | 0.01% | 871 |
|
|
2017
Q3 | $4.55M | Buy |
56,000
+8,600
| +18% | +$680K | 0.01% | 930 |
|
|
2017
Q2 | $3.81M | Sell |
47,400
-90,500
| -66% | -$7.15M | 0.01% | 950 |
|
|
2017
Q1 | $10.8M | Buy |
137,900
+63,700
| +86% | +$5.09M | 0.05% | 354 |
|
|
2016
Q4 | $5.86M | Sell |
74,200
-228,700
| -76% | -$18.5M | 0.03% | 573 |
|
|
2016
Q3 | $27M | Buy |
302,900
+108,000
| +55% | +$10.2M | 0.13% | 146 |
|
|
2016
Q2 | $18.7M | Buy |
194,900
+180,700
| +1,273% | +$18M | 0.09% | 202 |
|
|
2016
Q1 | $1.47M | Sell |
14,200
-56,900
| -80% | -$5.53M | 0.01% | 1481 |
|
|
2015
Q4 | $6.95M | Buy |
71,100
+29,900
| +73% | +$2.93M | 0.04% | 373 |
|
|
2015
Q3 | $3.98M | Buy |
41,200
+38,000
| +1,188% | +$3.99M | 0.02% | 549 |
|
|
2015
Q2 | $336K | Hold |
3,200
| – | – | ﹤0.01% | 2689 |
|
|
2015
Q1 | $330K | Buy |
+3,200
| New | +$324K | ﹤0.01% | 2435 |
|
Other funds holding CVS
VCM
VPM
Jane Street's CVS Position: Q1 2026 in Review
Jane Street reduced its CVS Health (CVS) stake by 18% in Q1 2026, selling an estimated $1.3M and leaving 75,453 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3387.
Jane Street first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $169M in Q4 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Jane Street held 75,453 shares of CVS Health worth $5.42M as of Q1 2026.
- Jane Street sold 16,823 CVS Health shares in Q1 2026, an estimated $1.3M.
- CVS Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3387 holding.
- Jane Street first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
- Jane Street's CVS Health position peaked at $169M in Q4 2024.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.